进行性肺纤维化
非特发性肺纤维化(IPF)病例中相当一部分呈现「IPF样」病程,称为进行性肺纤维化(PPF),与死亡率增加相关。识别PPF的影像学标准之一是尽管接受常规治疗,系列高分辨率CT仍显示纤维化进展,可表现为纤维化总体范围增加,或总体范围不变但严重程度增加。放射科医生在识别PPF中起关键作用,准确识别影像学进展可能使患者开始抗纤维化药物治疗,该治疗已被证明可显著减少后续肺功能下降。
要点
- 非IPF间质性肺病可呈「IPF样」进展,称为进行性肺纤维化(PPF),与死亡率增加相关。
- PPF的影像学进展标准:纤维化总体范围增加,或总体范围不变但严重程度增加。
- 放射科医生准确识别影像学进展,可能使患者开始抗纤维化药物以减缓肺功能下降。
核心结论
- 非IPF病例中相当一部分呈「IPF样」病程即进行性肺纤维化(PPF),与死亡率增加相关;影像学进展是识别PPF的标准之一,放射科医生准确识别进展可能使患者开始抗纤维化药物,该药已显示可显著减少后续肺功能下降。
研究设计与样本
- 本文为综述性文章,围绕非IPF间质性肺病中进行性肺纤维化(PPF)的影像学识别进行阐述,原文未报告系统检索范围与纳入文献数量。
关键影像表现/征象
- 系列高分辨率CT上纤维化进展可表现为纤维化总体范围增加。
- 纤维化总体范围不变但严重程度增加,也应被识别为进展。
诊断标准与关键数值
- PPF的识别标准之一为:尽管接受常规治疗,系列高分辨率CT仍显示纤维化进展。
- 影像学进展定义为纤维化总体范围增加,或总体范围不变但严重程度增加。
临床应用与阅片要点
- 放射科医生在PPF患者管理中起关键作用,准确识别影像学进展可能使患者开始抗纤维化药物。
- 阅片时除关注纤维化总体范围增加外,还需注意总体范围不变但严重程度增加的情况,也应判为进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A significant number of non-idiopathic pulmonary fibrosis (IPF) cases follow an 'IPF-like' trajectory, known as progressive pulmonary fibrosis (PPF). PPF is associated with increased mortality. One of the criteria for identifying PPF is progression of fibrosis despite conventional treatment on serial high-resolution computed tomography. Progression may be identified by an increased overall extent of fibrosis on CT. However, an increased severity with the same overall extent should also be identified as progression. Radiologists play a critical role in the management of patients with PPF, as the accurate identification of radiological progression may allow patients to commence antifibrotic drugs, which have been shown to significantly reduce subsequent decline in lung function. KEY POINTS: Question Non-idiopathic pulmonary fibrosis (IPF) disease can follow an 'IPF-like' trajectory, known as progressive pulmonary fibrosis (PPF), which is associated with increased mortality. Findings One criterion for PPF is radiological progression, characterised by an increased overall extent or an increaed severity with the same overall extent. Clinical relevance Radiologists play a critical role in identifying PPF, which may allow patients to commence antifibrotic drugs.
引用
- Bajwa R, Lancaster D, Desai SR, et al. Progressive pulmonary fibrosis. Eur Radiol. 2025. PMID: 41417118. doi:10.1007/s00330-025-12212-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。